The parent of BioReference Labs is sending some bullish signals amid a nice recent run higher in its shares.
Plus, a closer look at Thursday's late-day rally and at actions impacting the nation's big banks.
Indonesian stocks have done poorly this year, but these nine stocks could rate attention if investors rediscover the market.
EW's charts are constructive, but prices need to push up into resistance to signal that a breakout is possible.
Thursday's rally was sparked by news that Moderna's Covid-19 vaccine candidate is moving to Phase II testing.
The charts and indicators of ARE are heading in the right direction but not with convincing volume.
CEO McMullen said it's not a matter of if they'll have a vaccine, but when.
The drugmaker that is partnering with Sanofi to develop a vaccine has seen its shares push higher after declining to a low in late March.
With a strong history in an important industry, Becton Dickinson looks set to provide and increase its dividend through this crisis and beyond.
The technical signals for the technology provider to the life science industry show its shares have upside potential.